Endocuff Vision 提高腺瘤检出率:ADENOMA 随机对照试验
这项多中心随机对照试验在七家医院招募因症状、监测或粪便隐血试验阳性转诊的患者,比较 Endocuff Vision 辅助结肠镜与标准结肠镜的腺瘤检出率。结果显示 Endocuff Vision 将总体腺瘤检出率从 36.2% 提高至 40.9%(P=0.02),增幅主要来自粪便隐血试验阳性筛查患者(标准结肠镜 50.9% vs Endocuff Vision 61.7%,P<0.001)。
要点
- Endocuff Vision 辅助结肠镜使总体腺瘤检出率从 36.2% 升至 40.9%(P=0.02)。
- 粪便隐血试验阳性筛查患者腺瘤检出率标准结肠镜 50.9% vs Endocuff Vision 61.7%(P<0.001)。
- Endocuff Vision 组癌检出率 4.1% vs 标准结肠镜 2.3%(P=0.02),无显著不良事件。
核心结论
- Endocuff Vision 显著提高了肠道癌症筛查患者的腺瘤检出率,应使用以提高结肠镜检出。
研究设计与样本
- 多中心随机对照试验,从七家医院招募因症状、监测或粪便隐血试验阳性转诊的患者,共 1772 例(57% 男性,平均年龄 62 岁),16 个月内招募,45% 通过筛查招募。
主要发现
- Endocuff Vision 辅助结肠镜将总体腺瘤检出率从 36.2% 提高至 40.9%(P=0.02)。
- 粪便隐血试验阳性筛查患者腺瘤检出率标准结肠镜 50.9% vs Endocuff Vision 61.7%(P<0.001),增幅为 10.8%。
- Endocuff Vision 组每例平均腺瘤数、无蒂锯齿状息肉、左侧、微小、小腺瘤和癌的检出率更高(癌 4.1% vs 2.3%,P=0.02)。
- Endocuff Vision 移除率为 4.1%;中位插管时间 Endocuff Vision 组快 1 分钟(P=0.001),盲肠插管率和退镜时间无差异。
- Endocuff Vision 耐受良好,但在无或轻微镇静患者中肛门插管时不适感轻微增加;无显著 Endocuff Vision 不良事件。
临床怎么用
- 原文结论认为 Endocuff Vision 应使用以提高结肠镜检出。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Low adenoma detection rates (ADR) are linked to increased postcolonoscopy colorectal cancer rates and reduced cancer survival. Devices to enhance mucosal visualisation such as Endocuff Vision (EV) may improve ADR. This multicentre randomised controlled trial compared ADR between EV-assisted colonoscopy (EAC) and standard colonoscopy (SC). DESIGN: Patients referred because of symptoms, surveillance or following a positive faecal occult blood test (FOBt) as part of the Bowel Cancer Screening Programme were recruited from seven hospitals. ADR, mean adenomas per procedure, size and location of adenomas, sessile serrated polyps, EV removal rate, caecal intubation rate, procedural time, patient experience, effect of EV on workload and adverse events were measured. RESULTS: 1772 patients (57% male, mean age 62 years) were recruited over 16 months with 45% recruited through screening. EAC increased ADR globally from 36.2% to 40.9% (P=0.02). The increase was driven by a 10.8% increase in FOBt-positive screening patients (50.9% SC vs 61.7% EAC, P<0.001). EV patients had higher detection of mean adenomas per procedure, sessile serrated polyps, left-sided, diminutive, small adenomas and cancers (cancer 4.1% vs 2.3%, P=0.02). EV removal rate was 4.1%. Median intubation was a minute quicker with EAC (P=0.001), with no difference in caecal intubation rate or withdrawal time. EAC was well tolerated but caused a minor increase in discomfort on anal intubation in patients undergoing colonoscopy with no or minimal sedation. There were no significant EV adverse events. CONCLUSION: EV significantly improved ADR in bowel cancer screening patients and should be used to improve colonoscopic detection. TRIAL REGISTRATION NUMBER: NCT02552017, Results; ISRCTN11821044, Results.
引用
- Ngu WS, Bevan R, Tsiamoulos ZP, et al. Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial. Gut. 2018. PMID: 29363535. doi:10.1136/gutjnl-2017-314889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。